Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Immune System Regulation AB logo — An innovation driven research company with the objective to...

Immune System Regulation AB

An innovation driven research company with the objective to develop drugs for treatments of viral infections and cancer.

Sweden Sweden 1 employees

General Information

Company Name Immune System Regulation AB
Location Sweden Sweden +1
Employees 1
Social

Get notified when Immune System Regulation AB moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Immune System Regulation AB

Immune System Regulation AB is an innovation-driven research company based at the Karolinska Hospital in Stockholm, Sweden. The company's objective is to develop drugs for the treatment of viral infections and cancer through a focus on preclinical and clinical research within the field of immunotherapy. With a mission to be at the forefront of immunotherapy, ISR aims to develop curative drugs for cancer, HIV, Covid-19, HBV, and other infections. The company's dedication to advancements in immunotherapy positions it as a key player in addressing critical medical challenges. As an investor, keeping an eye on ISR and its pioneering work in the development of treatments for impactful diseases presents an opportunity to contribute to groundbreaking advancements in medical science.

Taxonomy: research company, immunotherapy, viral infections, cancer, preclinical research, clinical research, curative drugs, treatment, innovation-driven, Karolinska Hospital, Stockholm, Sweden, HIV, Covid-19, HBV

No funding data available for Immune System Regulation AB yet.

Get notified when Immune System Regulation AB raises funding

Immune System Regulation AB Alternatives & Competitors

Immune System Regulation AB vs
Immupeutics Medicine
Immupeutics Medicine

Advancing the future of tumor treatment through innovative research and application in immunotherapy...

Seed
11-50 employees
Biotechnology
Immune System Regulation AB vs
ImmuniT Research
ImmuniT Research

Pioneering Advances in Immunotherapy with Daily Precision.

Series Unknown
Biotechnology, Care Economy
Immune System Regulation AB vs
Noile-Immune Biotech
Noile-Immune Biotech

Pioneering the future of cancer immunotherapy with CAR-T cell advancements from academic innovation.

Series C
Biotechnology

FAQ About Immune System Regulation AB

An innovation driven research company with the objective to develop drugs for treatments of viral infections and cancer.
Immune System Regulation AB is headquartered in Sweden.
Immune System Regulation AB has approximately 1 employees.
Top alternatives and competitors to Immune System Regulation AB include Immupeutics Medicine, ImmuniT Research, Noile-Immune Biotech, KaliVir Immunotherapeutics, Caedo Oncology AS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immune System Regulation AB and Immupeutics Medicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Immune System Regulation AB and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy